home / stock / eyeg / eyeg short
Short Information | Eyegate Pharmaceuticals Inc. (NASDAQ:EYEG)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 12,936 |
Total Actual Volume | 27,458 |
Short Trends | |
---|---|
Cover Days | 7 |
Short Days | 12 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 647 |
Average Short Percentage | 55.72% |
Is there a EYEG Short Squeeze or Breakout about to happen?
See the EYEG Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-16-2024 | $35.7865 | $35.92 | $35.92 | $35.7865 | 2,164 | 1,075 | 49.68% |
07-11-2024 | $35.81 | $35.7803 | $35.81 | $35.7803 | 840 | 139 | 16.55% |
07-10-2024 | $35.5968 | $35.5968 | $35.5968 | $35.5968 | 2 | 2 | 100% |
07-09-2024 | $35.5116 | $35.545 | $35.545 | $35.5116 | 627 | 625 | 99.68% |
07-08-2024 | $35.615 | $35.615 | $35.615 | $35.615 | 5 | 1 | 20% |
07-05-2024 | $35.58 | $35.58 | $35.58 | $35.58 | 2 | 1 | 50% |
07-02-2024 | $35.1896 | $35.1896 | $35.1896 | $35.1896 | 3 | 1 | 33.33% |
07-01-2024 | $35.0184 | $35.0302 | $35.0302 | $35.0184 | 2,300 | 2,300 | 100% |
06-18-2024 | $35.685 | $35.69 | $35.7 | $35.6539 | 1,453 | 751 | 51.69% |
06-17-2024 | $35.54 | $35.54 | $35.54 | $35.54 | 9 | 5 | 55.56% |
06-10-2024 | $35.19 | $35.19 | $35.19 | $35.19 | 130 | 130 | 100% |
06-06-2024 | $35.535 | $35.535 | $35.535 | $35.535 | 3 | 2 | 66.67% |
05-17-2024 | $35.36 | $35.32 | $35.36 | $35.27 | 6,602 | 1,600 | 24.24% |
05-14-2024 | $35.1798 | $35.1798 | $35.1798 | $35.1798 | 3 | 1 | 33.33% |
05-08-2024 | $35.0936 | $35.0936 | $35.0936 | $35.0936 | 4 | 1 | 25% |
05-07-2024 | $35.1757 | $35.1757 | $35.1757 | $35.1757 | 1 | 1 | 100% |
04-29-2024 | $34.84 | $34.8561 | $34.88 | $34.81 | 4,001 | 600 | 15% |
04-19-2024 | $34.715 | $34.705 | $34.77 | $34.705 | 5,800 | 3,800 | 65.52% |
04-16-2024 | $34.52 | $34.5477 | $34.57 | $34.52 | 1,500 | 800 | 53.33% |
04-11-2024 | $34.9188 | $34.895 | $34.93 | $34.895 | 2,009 | 1,101 | 54.8% |
News, Short Squeeze, Breakout and More Instantly...
Eyegate Pharmaceuticals Inc. Company Name:
EYEG Stock Symbol:
NASDAQ Market:
LONDON, UK / ACCESSWIRE / December 9, 2022 / Kazia Therapeutics has announced the publication of pre-clinical data for its second pipeline asset, EVT801 in the journal Cancer Research Communications. The research was conducted by licensing partner Evotec and was the key driver for Kazia in-licen...
LONDON, UK / ACCESSWIRE / December 7, 2022 / With its H123 interim results, ReNeuron highlighted progress across its proprietary exosome platform, CustomEx. The company reported H123 revenues of £438k (H122: £58k), primarily related to income associated with a £320k payment from F...
WALTHAM, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announc...